1 / 56

Rapid Sequence Intubation

Rapid Sequence Intubation. Anthony G. Hillier, D.O. EM Resident St. John West Shore . Rapid Sequence Intubation.

emily
Download Presentation

Rapid Sequence Intubation

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Rapid Sequence Intubation Anthony G. Hillier, D.O. EM Resident St. John West Shore

  2. Rapid Sequence Intubation • The induction of a state of unconsciousness with complete neuromuscular paralysis to achieve intubation without interposed mechanical ventilation in efforts to facilitate the procedure and minimize risks of gastric aspiration

  3. Rapid Sequence IntubationIndications • Failure of airway maintenance/protection - lost or diminished gag reflex • Failure of oxygenation/ventilation - pulmonary edema, COPD • Anticipated clinical course - multiple trauma, head injured - intoxication, air transport

  4. Preparation: T-10” Positioning Preoxygenation: T-5” Premedication: T-3” Paralysis:T-0 Placement of tube: T+45 Post management: T+2” Rapid Sequence Intubation“6 P’s”

  5. Preparation

  6. Preparation • Evaluate • LEMON • Equipment Check • Positioning • Drug Selection • IV’s, monitor, oximetry • Ancillary Staff • Anticipate alternative airway maneuver

  7. Preparation • LEMON • L-look • E-evaluate the 3-3-2 rule • M-Mallampati • O-Obstruction • N-Neck mobility

  8. PREOXYGENATION

  9. Preoxygenation • 100% O2 for 5 minutes of 5 vital capacity breaths can theoretically permit 3-5 minutes of apnea before desaturation to less than 90% occurs

  10. Preoxygenation • “nitrogen wash-out” • Avoid bagging the patient if adequately preoxygenated

  11. PREMEDICATION

  12. Premedication • Goal is to blunt the patient’s physiologic responses to intubation • Minimizes bradycardia, hypoxemia, cough/gag reflex, increases in intracranial, intraocular, and intragastric pressures

  13. Premedication • Lidocaine • Opioid • Atropine • Defasciculating doses “priming”

  14. Lidocaine • Thought to blunt the rise in intracranial pressure associated with airway manipulation and the use of depolarizing neuromuscular blocking agents • 1.5-3.0 mg/kg (average 100mg) three minutes prior to intubation

  15. Atropine • 0.02 mg/kg, minimum 0.1 mg IV, max 1 mg, three minutes prior to intubation • Can minimize vagal effects, bradycardia and secretions • Infants and children < 8 years may develop profound bradycardia during intubation

  16. Defasciculating doses • Decreases muscle fasiculations caused by the depolarizing agents (succinylcholine) • Attenuates rise in intracranial pressure • Agents used are the non-depolarizing blocking agents (vecuronium, pancuronium etc.) usually 1/10 of standard dose

  17. Sedation • Sedative agents administered at doses capable of producing unconsciousness with little or no cardiovascular effects • No ideal agent exists • Sedation should nearly always be used when paralyzing the patient

  18. Sedation • Barbiturates/hypnotics • Non-barbiturate • Neuroleptics • Opiates • Benzodiazepines

  19. Barbiturates/Hypnotics • Thiopental (Pentothal), Methohexital (Brevital) • Short onset (10-20) seconds, duration 5-10 minutes • May reduce intracranial pressure, cerebro-protective • Histamine release, hypotension, bronchospasm

  20. Barbiturates/Hypnotics • Etomidate (Amidate) a nonbarbiturate hypnotic • Decreases ICP/IOP • Rapid onset, short duration • Minimal hemodynamic effects • No histamine release • Increases seizure threshold

  21. Etomidate • No malignant hyperthermia reported • Watch for myoclonus, vomiting • May decrease cortisol synthesis (adrenal insufficiency) • Dose 0.3 mg/kg IV

  22. Propofol • Propofol (Diprivan), sedative hypnotic • Extremely rapid onset (10 sec), duration of 10-15 minutes • Decreases ICP • Can cause profound hypotension • Dose 1-3 mg/kg IV for induction • Dose: 100-200 mcg/kg/min for maintenance

  23. Ketamine • Ketamine-dissociative anesthetic • Rapid onset, short duration • Potent bronchodilator, useful in asthmatics • Increases ICP, IOP, IGP • Contraindicated in head injuries • Increases bronchial secretions

  24. Ketamine • “Emergence” phenomenon can occur though rarely in children less than 10 years • Emergence reactions occur in up to 50% of adults • Dose: 1-2 mg/kg

  25. Opiates

  26. Fentanyl • Fentanyl • Broad dose-response relationship • Can be reversed with naloxone • Fentanyl is rapid acting (<1 min), duration of 30 min • Does not release histamine

  27. Fentanyl • May decrease tachycardia and hypertension associated with intubation • Seizures and chest wall rigidity have been reported • Dose: 2-10 mcg/kg IV

  28. Morphine Sulfate • Longer onset (3-5) minutes and duration (4-6) hours • May not blunt the rise in ICP, hypertension and tachycardia as well as fentanyl • Dose 0.1-0.2 mg/kg IV • Histamine release

  29. Benzodiazepines

  30. Benzodiazepines • Midazolam, Diazepam, Lorazepam • Provide excellent amnesia and sedation • Broad dose-response relationship • Reversed with Flumazenil (Romazicon) • Doses required are higher for RSI than for general sedation

  31. Midazolam • Slower onset (3-5) min than the barbiturate/hypnotic agents • Considered short-acting (30-60 min) • Does not increase ICP • Causes respiratory and cardiovascular depression • Dose: 0.1-0.4mg/kg IV

  32. Diazepam and Lorazepam • Moderate/long acting agents • Longer onset time than midazolam • May be more beneficial post-intubation for sedation

  33. Paralysis

  34. Neuromuscular Blocking Agents • Chemical paralysis facilitates intubation by allowing visualization of the vocal cords and optimizing intubating condition • Only CONTRAINDICATION is anticipated difficult airway • Mallampati Class • Thyromental Distance

  35. Depolarizing Agents • Exert their affect by binding with acetylcholine receptors at the neuromuscular junction, causing sustained depolarization of the muscle cell

  36. Nondepolarizing • Bind to acetylcholine receptors in a competitive, non-stimulatory manner, no receptor depolarization • Histamine release • Agents can be reversed with edrophonium or neostigmine • Caution with myasthenia gravis

  37. Depolarizing agents • Succinylcholine (Anectine) • Nondepolarizing Agents • Pancuronium (Pavulon) • Vecuronium (Norcuron) • Atracurium (Tracrium) • Rocuronium (Zemuron) • Mivacurium (Mivacron)

  38. Succinylcholine • Stimulates nicotinic/muscarinic cholinergic receptors • Gold standard for 50 years • Onset 45 seconds, duration 8-10 minutes • Dose: (adults 1.5 mg/kg IV) • Children 2.0 mg/kg IV • Inactivated by pseudocholinesterase

  39. Succinylcholine cont • Prolonged paralysis seen with: • Pregnancy • Liver disease • Malignancies • Cytotoxic drugs • Certain antibiotics • Cholinesterase inhibitors • Organophosphate poisoning

  40. Succinylcholine • Adverse reactions • Muscle fasiculations • Hyperkalemia • Bradycardia • Prolonged neuromuscular blockade • Trismus • Malignant hyperthermia

  41. Depolarizing Agents • Muscle fasiculations • Thought to increase ICP/IOP/IGP • Causes muscle pain • Minimized by “priming” dose of NMB • Hyperkalemia • Average increase in potassium of 0.5-1 mEq/L • Burns, crush injuries, spinal cord injuries, neuromuscular disorders, chronic renal failure

  42. Depolarizing agents • Bradycardia • Most common in children <10 years due to higher vagal tone • Also with repeated doses of succinylcholine • Premedicate with atropine

  43. Depolarizing Agents • Malignant hyperthermia • From excessive calcium influx through open channels • Genetic predisposition • Rapid temperature, rhabdomyolysis, muscle rigidity, DIC • 60% mortality • Treatment: IV Dantrolene

  44. Depolarizing Agents • Trismus (Masseter spasm) • Usually in children • Unknown cause • Treat with a nondepolarizing NMB

  45. Pancuronium • Long-acting agent (45-90 min) • Slow onset (1-5 min) • Renal excretion • Vagolytic tachyarrythmias common • Dose: 0.10-0.15 mg/kg IV

  46. Vecuronium • Duration of 30-60 min • Onset of 1-4 min • Hypotension may occur from loss of venous return and sympathetic blockade • Mostly biliary excretion • Dose 0.1 mg/kg • “priming dose” 0.01 mg/kg

More Related